BARINTHUS BIOTHERAPEUTICS PL (BRNS) Institutional Ownership and Insiders Activity

BARINTHUS BIOTHERAPEUTICS PL (BRNS) is widely held by institutional investors, with 14 firms reporting positions valued at approximately $7.82M based on SEC Form 13F filings for the quarter ended June 30, 2026.

M&G Plc is the largest disclosed holder, reporting approximately $5.20M in BRNS holdings in its latest filing.

Institutional ownership remains highly concentrated, with M&G Plc representing the majority of disclosed value.

Recent insider activity includes 9 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.